Suppr超能文献

[卡托普利对心肌梗死急性期左心室衰竭的影响]

[Effect of captopril in left ventricular failure during the acute stage of myocardial infarction].

作者信息

Kayanakis J G, Breton J, Maillet J, Fauvel J M, Bounhoure J P

出版信息

Arch Mal Coeur Vaiss. 1983 Dec;76(12):1369-74.

PMID:6422872
Abstract

The oral inhibitor of the converting enzyme of angiotensin has previously been used successfully in the treatment of chronic cardiac failure. Its action as an arterial and venous vasodilator and in significantly reducing the heart rate which we have previously reported, led us to assess its effects in left ventricular failure during acute myocardial infarction. The effects of captopril were compared with those of isosorbide dinitrate in 10 patients with left ventricular failure during acute myocardial infarction. An arterial and venous vasodilatation was obtained with both drugs. Captopril induced a greater fall in left ventricular filling pressures and significantly reduced the heart rate, leading to a slight increase in left ventricular systolic work index. Pulmonary arterial resistances decreased more significantly with captopril whilst systemic arterial resistances fell equally. The left ventricular function curve was shifted to the left by both captopril and isosorbide dinitrate, but only captopril induced an upward shift and only captopril caused very significant reductions in the rate-pressure product. The plasma renin activity of these patients was high but the correlation with the vasodilator effect was poor. There was little change in medium-term survival (50% mortality). These results indicate that captopril may be a valuable drug in the treatment of left ventricular failure in acute myocardial infarction. However, its oral presentation makes it difficult to determine the optimal dose.

摘要

血管紧张素转换酶口服抑制剂此前已成功用于治疗慢性心力衰竭。其作为动脉和静脉血管扩张剂的作用,以及我们之前报道的显著降低心率的作用,促使我们评估其在急性心肌梗死所致左心室衰竭中的疗效。将卡托普利的疗效与硝酸异山梨酯在10例急性心肌梗死所致左心室衰竭患者中的疗效进行了比较。两种药物均能引起动静脉血管扩张。卡托普利使左心室充盈压下降幅度更大,并显著降低心率,导致左心室收缩作功指数略有增加。卡托普利使肺动脉阻力下降更为显著,而体动脉阻力下降程度相同。卡托普利和硝酸异山梨酯均使左心室功能曲线向左移位,但只有卡托普利引起向上移位,且只有卡托普利使速率-压力乘积显著降低。这些患者的血浆肾素活性较高,但与血管扩张作用的相关性较差。中期生存率变化不大(死亡率50%)。这些结果表明,卡托普利可能是治疗急性心肌梗死所致左心室衰竭的一种有价值的药物。然而,其口服剂型使得难以确定最佳剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验